Long-Term Debt: The sum of all long term debt fields.
Neuphoria Therapeutics Inc. (NEUP) Long-Term Debt data is not available for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
$1.17M |
|
$-13.45M |
|
-- |
|
$1.17M |
|
$17.63M |
|
$-16.45M |
|
$2.86M |
|
$-13.59M |
|
$-13.59M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-16.45M |
|
$-15.79M |
|
4.40M |
|
4.40M |
|
$-3.06 |
|
$-3.06 |
|
| Balance Sheet Financials | |
$21.07M |
|
-- |
|
$7.64M |
|
$28.71M |
|
$0.76M |
|
|
Long-Term Debt |
-- |
$3.35M |
|
$4.11M |
|
$24.60M |
|
$16.96M |
|
$24.60M |
|
5.41M |
|
| Cash Flow Statement Financials | |
$-12.35M |
|
-- |
|
$17.92M |
|
$14.29M |
|
$19.87M |
|
$5.58M |
|
$0.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1401.09% |
|
-1401.09% |
|
-1344.62% |
|
-1157.51% |
|
-1145.66% |
|
$-12.35M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.44 |
|
252.86 |
|
-54.68% |
|
-79.32% |
|
-46.86% |
|
-54.68% |
|
$4.55 |
|
$-2.81 |
|
$-2.81 |
|